<>
<>
<>
<>
<>
<>
<>
MindVision
With the Indian CNS market growing at about 20%, Mindvision has driven Lupin's entry into the neuro-psychiatry segment. One of the fastest growing divisions of Lupin's India Region Formulations, Mindvision registered a growth of 41% in FY 2010 and including the oncology division recorded a growth of 46%.

Key Products : MindVision

Product

Therapeutic Segment

Product Rank in in the relevant segment

Stalopam

Escitalopram

2

Placidox

Diazepam

3

Arzu

Aripiprazole

3

Fibril

Bulk Producers

5

Dulot

Duloxetine

6

Citistar

Citocholine

6


<>
<> <> <>
<>
<>
<>